The FemTech industry’s approach to PMOS
The article discusses the global renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its multisystem nature. It then analyzes India's FemTech industry's response, highlighting its integrated care models and market growth. However, the article critically examines the limitations of privatized FemTech care, such as issues of accessibility, market volatility, and the need for broader public healthcare reforms, improved medical education, and consideration of environmental factors for long-term solutions to chronic women's health conditions.
The article discusses the global renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its multisystem nature. It then analyzes India's FemTech industry's response, highlighting its integrated care models and market growth. However, the article critically examines the limitations of privatized FemTech care, such as issues of accessibility, market volatility, and the need for broader public healthcare reforms, improved medical education, and consideration of environmental factors for long-term solutions to chronic women's health conditions.
Exam linkage
GS Paper II - Social Justice (Issues relating to development and management of Social Sector/Services relating to Health; Welfare Schemes for vulnerable sections of the population).
Syllabus mapping
This topic appears in Mains
Questions on Social Justice & Development come up regularly in GS papers. Practice writing an answer — and see exactly what earns marks.